Vice President, Program Management
NervGen Pharma
Vancouver, British Columbia, Canada
Nana Collett, MS, MBA, has over 20 years experience managing biopharma product development programs from preclinical stage to Phase 3 across a range of therapeutic areas and modalities. Prior to joining NervGen, Ms. Collett has been an independent consultant and advisor to start-up companies. Prior to that, Ms. Collett was VP Program Management at Genevant Sciences and spent nine years with Arbutus Biopharma (formerly Tekmira Pharmaceuticals), most recently as VP Project Management. Prior to that, Ms. Collet held diverse roles at commercial stage biotech company QLT. Ms. Collett has a BSc (Honours) in Biology from University of British Columbia, an M.S. in Ecosystem Science from the University of Washington, and an MBA in Management of Biotechnology from Simon Fraser University.
NVG-291 Phase 1 Results and Phase 1b/2a Study Design in Individuals with Spinal Cord Injury
Tuesday, October 31, 2023
4:00 PM – 4:15 PM